Momentary increase in plasma calcitonin gene-related peptide is involved in hot flashes in men treated with castration for carcinoma of the prostate

Journal of Urology

Volumn 166, Issue 5, 2001, Pages 1720-1723

  Johnstone, Peter A S ^a   McFarland, Joel T ^b   Riffenburgh, Robert H ^b   Amling, Christopher L ^b  

^a NAVAL MEDICAL CENTER SAN DIEGO   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Calcitonin gene related peptide; Carcinoma; Castration; Hot flashes; Prostate

Indexed keywords

CALCITONIN GENE RELATED PEPTIDE;

ADULT; AGED; ARTICLE; CANCER SURGERY; CASTRATION; CLINICAL ARTICLE; HOT FLUSH; HUMAN; MALE; MALE GENITAL TRACT CANCER; PLASMA; PRIORITY JOURNAL; PROSTATE CARCINOMA; RADIOIMMUNOASSAY; SKIN TEMPERATURE; THERMOREGULATION; TREATMENT OUTCOME;

EID: 0034796026     PISSN: 00225347     EISSN: None     Source Type: Journal    
DOI: 10.1016/s0022-5347(05)65660-1     Document Type: Article

References (36)

1. Studies on prostatic cancer. II. The effect of castration of advanced carcinoma of the prostate gland
2. Prevalence and duration of hot flushes after surgical or medical castration in men with prostatic carcinoma
3. Pathophysiology of hot flushes
4. Menopausal hot flush
5. Measurement of skin blood-flow and water evaporation as a means of objectively assessing hot flushes after orchiectomy in patients with prostatic cancer
6. Laboratory and ambulatory monitoring of menopausal hot flashes
7. Elevations in skin temperature of the finger as an objective index of postmenopausal hot flashes: Standardization of the technique
8. Alteration of thermoregulatory set point with opioid agonists
9. Postmenopausal hot flushes and their management
10. Effects of sex steroids on β-endorphin in hypophyseal portal blood
11. Relationship between cerebrospinal fluid β-endorphin and plasma pituitary-gonadal hormone levels in women
12. The effect of estrogen and progestin on endogenous opioid activity in oophorectomized women
13. Opioid control of the release of calcitonin gene-related peptide-like material from the rat spinal cord in vivo
14. Calcitonin gene-related peptide (CGRP): Perivascular distribution and vasodilatory effects
15. Production of a novel neuropeptide encoded by the calcitonin gene via tissue-specific RNA processing
16. Coexistence of calcitonin gene-related peptide and vasoactive intestinal peptide in cholinergic sympathetic innervation of rat sweat glands
17. Immunohistochemical evidence suggests intrinsic regulatory activity of human eccrine sweat glands
18. The effect of calcitonin gene-related peptide (CGRP) on human forearm blood flow
19. Vasoactive peptides in the skin
20. Concentrations of calcitonin gene related peptide and neuropeptide Y in plasma increase during flushes in postmenopausal women
21. Changes of plasma calcitonin gene-related peptide levels in postmenopausal women
22. Menopausal flushes and calcitonin-gene-related peptide
23. Postmenopausal women with vasomotor symptoms have increased urinary excretion of calcitonin gene-related peptide
24. Urinary excretion of calcitonin gene-related peptide (CGRP) in males with hot flushes after castration for carcinoma of the prostate
25. Sample handling techniques when analyzing regulatory peptides
26. Direct measurement of skin conductance: A proposal for standardization
27. Management of hot flushes due to endocrine therapy for prostate carcinoma
28. Flushing. Long-term side effect of orchiectomy in treatment of prostatic carcinoma
29. Calcitonin gene-related peptide in treatment of severe peripheral vascular insufficiency in Raynaud's phenomenon
30. Relationship between sweat gland activity and electrical resistance of the skin
31. Long term use of megestrol acetate by cancer survivors for the treatment of hot flushes
32. Cyproterone acetate in treatment of post-orchiectomy hot flushes. Double-blind cross-over trial
33. Treatment of post-orchiectomy hot flashes with transdermal administration of clonidine
34. Acupuncture treatment of vasomotor symptoms in men with prostatic carcinoma: A pilot study
35. Pharmacological profile of BIBN4096BS, the first selective small molecule CGRP antagonist
36. CGRP 27-37 analogues with high affinity to the CGRP1 receptor show antagonistic properties in a rat blood flow assay